With increasing survival of preterm infants with bronchopulmonary dysplasia (BPD) it is critical to understand the clinical consequences on adult lung health.
had significantly lower values for FEV1 and FEF25-75 (% predicted and z scores) than term controls (both p<0.001). Although non-BPD subjects also had lower spirometric values than term controls, none of the differences reached statistical significance. More BPD subjects (25%) had fixed airflow obstruction than non-BPD (12.5%) and term (0%) subjects (p=0.004).
Both BPD and non-BPD subjects had significantly greater impairment in gas transfer (KCO % predicted) than term subjects (both p<0.05). Eighteen (37%) preterm participants were classified as small for gestational age (birth weight < 10th percentile for gestational age).
These subjects had significantly greater impairment in FEV1 (% predicted and z scores) than those born appropriate for gestational age. BPD survivors had significantly more severe radiographic structural lung impairment than non-BPD subjects. Both preterm groups had impaired exercise capacity compared to term controls. There was a trend for greater limitation and leg discomfort in BPD survivors.
Conclusions:
Adult preterm birth survivors, especially those who developed BPD, continue to experience respiratory symptoms and exhibit clinically important levels of pulmonary impairment.
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Children born prematurely and especially those who develope bronchopulmonary dysplasia (BPD) have more respiratory symptoms (1, 2) and greater lung function impairment persisting through adolescence than term born peers (2, 3, 4) Consequently concerns regarding the longer-term consequences of BPD include the early development of chronic obstructive pulmonary disease (COPD) (5, 6) . The adult respiratory health outcomes of BPD survivors are not well defined and our recent systematic review highlighted the limited number of small studies, some without suitable study controls (7) .
Although we have recently undertaken a study of adult survivors of BPD in their third and fourth decade of life and reported increased respiratory symptoms and substantial and clinically important reductions in lung function variables reflecting airflow obstruction compared to preterm and term controls, important knowledge gaps remain. Specifically, it is unclear whether lung impairment extends beyond the airway and if lung injury in early preterm life is associated with structural damage to surrounding lung tissue.
One small study of highly selected and symptomatic adult BPD subjects reported striking structural damage including emphysema (8) . Furthermore lung impairment may only become apparent during exercise and to date results from cardiopulmonary exercise testing have been conflicting. Vrijlandt and colleagues (9) confirmed reduced peak oxygen consumption in young adult BPD subjects compared to healthy controls. Lovering and colleagues (10) confirmed significantly reduced peak work rates and greater leg discomfort during exercise in preterm non-BPD and BPD subjects compared to term controls. In contrast, Narang et al (11) , found no evidence of exercise limitation in ex preterm subjects compared to term controls.
Based on the accumulating evidence we hypothesised greater structural and functional lung impairment in adult BPD survivors compared to preterm and term controls. Here we report on lung function (spirometry, lung volumes, diffusing capacity), lung clearance index, fractional exhaled nitric oxide (FeNO) measurements, exercise capacity and high resolution CT (HRCT) findings in an index group of adult survivors of BPD compared to preterm and term controls. We used a subset of our Premature Adult Lung Study (PALS) cohort which was previously published (12) and reported in abstract form (13, 14, 15, 16, 17) .
Methods

Study design and participants
The PALS cohort comprised adults previously cared for in the Regional Neonatal Intensive Care Unit (NICU) of the Royal Maternity Hospital, Belfast between January 1978 and April 1993. This unit was the regional centre providing a comprehensive neonatal service and received patients from all over Northern Ireland. 7 BPD was defined as the continued requirement for supplemental oxygen >28 postnatal days with chronic radiological changes and severity (mild, moderate or severe) was graded according to oxygen requirements at 36 weeks post menstrual age (18) . BPD subjects were compared with gender matched preterm non-BPD controls also cared for in the NICU but not requiring mechanical ventilation or prolonged respiratory support. Both preterm groups were of very low birth weights (VLBW: < 1500g). A second control group comprising full term individuals, with no history of respiratory disease was recruited.
Tracing and recruitment to PALS and this sub study ( Figure E1 ) is detailed in the online supplement. Consecutive subjects responding to an invitation to participate in this sub study and meeting study criteria were recruited. Subjects were excluded if physical or cognitive impairment was likely to prevent them undertaking study procedures. (See online supplement for full protocol). All participants gave written informed consent and the study was approved by the Office for Research Ethics Committees Northern Ireland (ORECNI, 11/NI/0042).
Testing Protocol: Visit one
Respiratory symptoms were recorded using the European Community Respiratory Health Survey (ECRHS) screening tool (19) . Quality of life was measured using the EuroQol (20) and lung function tests were carried out in the order described below.
Multiple breath washout tests were performed using a modified Innocor TM gas analyser (Innovision TM A/S, Odense, Denmark) and an open-circuit technique (21) with the lung clearance index calculated. FeNO was measured using the (NIOX TM MINO (Aerocrine AB, Sweden) according to ATS/ERS recommendations (22) .
Forced Vital Capacity (FVC), and Forced Expiratory Volume in one second (FEV1) and mid expiratory flow (FEF25-75) were measured in accordance with ATS/ERS guidance (23) using a Sensoromics Vmax Encore (Conshohocken, USA). Spirometric results were expressed as percent predicted and z-scores based on prediction equations provided by the Institute of Child Health (24).
Total Lung Capacity (TLC) and Residual Volume (RV) were measured using Helium dilution.
Diffusing capacities were measured using single breath diffusing capacity tests. Subjects omitted regular asthma medication the morning of testing.
BPD subjects and non-BPD controls underwent inspiratory and expiratory HRCT imaging of the chest on a 64-slice CT scanner (Siemens AG, Germany). All scans were scored independently and blindly by two expert radiologists (SG, JC) using a validated standardised scoring method (Table E1 online supplement) (25).
Testing Protocol: Visit Two
Exercise testing was performed using a standardised, symptom-limited, maximal exercise protocol, (Modified Bruce Protocol) (26) using ATS guidelines (27). Peak VO2 was defined as the average VO2 over the final 30 seconds of exercise. The anaerobic threshold was determined using the V slope method by two experienced observers (SC, JM). Exercise data were plotted as time weighted 10 second averages.
Statistical analysis
Continuous variables were summarised as mean (standard deviation, SD) if normally distributed and median (interquartile range, IQR) if skewed. For normally distributed variables group comparisons were made using one-way ANOVA (with Tukey's post-hoc all pairs simultaneous 95% confidence intervals for mean differences and p-values) or t-tests. We used linear regression modelling to compare lung function for those with BPD and Preterm Non BPD whilst adjusting for birth weight, gestational age and year of birth.
Logistic regression was used to compare symptoms between groups whilst adjusting for gender and current smoking status.
We undertook analysis to determine the effect of low birth weight for GA by comparing those born small for gestational age (SGA) with those born at an appropriate weight for gestation (AGA). SGA was defined as a birth weight < 10th percentile for gestational age using the 1990 British Growth Standard (28). These comparisons of SGA and AGA subgroups required weighting to take account of the different selection probabilities for the BPD and non-BPD subgroups inherent in our study design. Current smoking status, BMI and physician diagnosed asthma were not significantly different among groups. One BPD subject was receiving inhaled corticosteroids and a short acting beta 2 agonist and 2 others were prescribed short acting beta 2 agonists alone. No non-BPD subjects were prescribed inhaled corticosteroids although one was prescribed a short acting beta 2 agonist. One term control had been prescribed an inhaled corticosteroid/long acting beta 2 agonist while 3 others took short acting beta 2 agonists alone.
There were no significant differences in gestation between BPD subjects recruited and those not responding to invitation but the responders were on average 150 lighter in birth weight (Table E2 , online supplement).
Respiratory symptoms
BPD subjects were at almost 10 times more likely to report being woken by coughing (OR 9.7, 95% CI: 1.8 to 52.6), p<0.01), and were over 4 times more likely to report being breathless when wheezing (OR 4.3, 95%CI: 1.1 to 16.8), p<0.05) in the last 12 months compared to term controls after adjusting for gender and current smoking (Table E3 online supplement). BPD subjects had significantly lower EQ-5D utility score than term controls (p<0.01) and reported lower scores on EQ-5D VAS compared with non-BPD, although this was not statistically significant (Table E4 , online supplement).
Lung function
Significant differences were apparent between the 3 groups in all lung function tests with the exception of RV % predicted, TLC % predicted and RV/TLC ratio ( Table 2 and Figure 1 ).
BPD subjects had significantly lower values for all spirometric measures than term controls.
Although non-BPD subjects also had lower spirometric values than term controls, none of the differences reached statistical significance.
BPD subjects had significantly lower mean values for FEV1, FVC and FEF25-75 compared to non-BPD controls whether expressed as percent predicted or z-scores (Table 2 ). Of the 7 BPD subjects who had an FEV1/ FVC ratio < 70 % predicted only 2 had significant reversibility defined as change in FEV1 of > 400mls and FEV1 % predicted > 15 % after bronchodilator (23).
While not statistically significant, RV/TLC ratios were higher in the BPD subjects than preterm and term controls. Diffusing capacities TLCO and KCO % predicted values were similar in BPD and non-BPD subjects and both were significantly lower than term controls (both p<0.001).
Significantly more BPD subjects had airflow reductions in the abnormally low range defined as FEV1 < 80% predicted, FEV1/FVC <70%, FEF25-75 < 60% predicted, TLCO % predicted < 80%, KCO % predicted <80%). Almost one quarter of the BPD group had FEV1 <80% compared to none of the term controls. Similarly, 60% of BPD subjects had FEF25-75 <60% compared to less than 5% of term controls.
Abnormally increased RV/TLC ratios (i.e. >120 % predicted) were recorded in 38% of BPD subjects compared with less than 5% of term controls. 43% of BPD subjects had abnormally low TLCO % predicted and 23 % abnormally low KCO % predicted compared to term controls (4% and 0% respectively) (both p<0. 01) . Compared to non-BPD controls, significantly more BPD subjects had abnormally low FEF25-75 % predicted values (p<0.01) (Table E5 online supplement).
As our study population comprised adults born preterm over a 15 year time span we considered the possibility that our comparisons of groups could be confounded by birth cohort effects as well as by birth weight and gestational age differences. Regression analysis of the lung function measurements (Table E6 online supplement).
Lung Clearance Index
Lung clearance index scores were significantly higher in BPD subjects [median (IQR) 7.0 (6.7-7.9)] compared to non-BPD [6.1 (5.9-6.9)] and term controls [6.6 (5.9-7.0)] (p=0.016 and p=0.003). Using our recently published normal values [mean (SD) 6.5 (0.5)] for lung clearance index by multiple breath washout on the same device in a cohort (n=30) of healthy controls (Section E1.2) (29) more BPD subjects (n=6) had abnormal lung clearance index values (> 1.96 SD score i.e. > 7.5) compared with non-BPD (n=2) and term (n=1) controls (p=0.055).
Thirty percent of BPD subjects with normal FEV1 (>80% predicted) had abnormal lung clearance index measurements (22) .
FeNO measurements
Although FeNO measurements were lower in both BPD subjects (median 19, IQR: 12 to 28 ppb) and non-BPD controls (median 19, IQR: 12 to 28 ppb) compared to term controls (median 27, IQR: 14 to 43 ppb) neither result attained statistical significance.
Lung function of subjects with low versus appropriate birth weight for gestational age
Eighteen (37%) preterm participants were classified as SGA (birth weight < 10 th percentile for gestational age). Data are presented in table 3. The SGA participants had been born at significantly greater gestational age than AGA (mean difference (95%CIs), -2.4 weeks (1.5 to 4.1), p < 0.001). SGA subjects had significantly greater impairment in FEV1 (% predicted than those born AGA (mean difference (95%CI), -9.8 (-19.3 to -0.2), p<0.05) but this difference did not retain its significance after weighting the analysis to allow for the higher sampling fraction of BPD subjects than non-BPD subjects. Those with BPD were no more likely to be SGA as preterm non-BPD (32% versus 42%, chi-squared p=0.69).
HRCT chest Imaging
BPD subjects had higher HRCT scan severity scores than non-BPD (p=0.0001) and all BPD subjects had some degree of HRCT abnormality ( Figure E2 and E3, Table 4 ). Sub-pleural opacities were the most common abnormality detected, and more common in BPD than non-BPD subjects (96% v 43%, p<0.001). Hypoattenuation on expiration (gas trapping) and bullous disease were significantly more common in BPD than non-BPD (65% v 30%, and 22% v 0%, both p<0.05). There were no significant differences in emphysema, bronchiectasis or bronchial wall thickening between groups.
When all preterm subjects were considered together, increasing HRCT score severity correlated significantly with measures of airflow obstruction (lower FEV1 z-scores, FEV1/FVC z-scores, FEF25-75 z-scores) and hyperinflation (increased RV/TLC ratio). When only BPD subjects were considered, only the correlation between HRCT score and RV/TLC ratio remained significant.
Cardiopulmonary exercise testing
Exercise data were obtained from 22 BPD subjects, 20 non-BPD and 24 term controls ( Table   5 ). Two BPD subjects were unable to perform the test because of cerebral palsy. One BPD subject, 2 non-BPD and 1 term control failed to attend. A greater proportion of term controls exercised more than 3 hours/week with no other significant differences in weekly activity levels among study groups. Fatigue and dyspnoea were the most common reason for terminating the test in each group. More subjects with BPD (n=7) reported leg discomfort during exercise than non-BPD (n=4) and term controls (n=3). BPD subjects had significantly lower peak VO2 than term controls [Mean (SD) ml/kg/min: 35.6 (7.5) vs. 45.2 (11.3) (p<0.01) and travelled significantly less distance than term controls of BPD subjects (n=6) failed to attain >84% of their predicted target heart rate. Even when these subjects were excluded the significant differences in peak VO2 between BPD subjects and term controls remained [Mean (SD) ml/kg/min: 36.9 (7.2) vs. 46.1 (10.8) (p<0. 01). BPD subjects achieved lower peak VO2 and travelled shorter distances than non-BPD but these differences were not statistically significant.
At peak exercise, BPD subjects had significantly lower peak heart rates than term controls (mean (SD) bpm: 173(13) vs. 186 (14) , p<0.001). Ventilatory equivalents for CO2 and O2 at the AT were greater in the BPD group than in the term controls, but there were no significant differences in ventilatory reserve or maximum respiratory rates between BPD subjects and term controls. BPD subjects had significantly lower minute ventilation (VE Measures of airflow obstruction [FEV1 % predicted (r=0.29, p=0.001), FEV1/FVC ratio (r=0.01, p=0.05) and FEF25-75 % predicted (r=0.32, p=0.04] were significantly correlated with impaired exercise capacity in adult survivors of BPD. However, HRCT scan severity scores were not associated with exercise capacity in preterm adults. There were no neonatal factors that could significantly predict impaired exercise capacity in preterm subjects.
Discussion
In this study, we confirm that individuals born prematurely, in particular those who developed BPD, have clinically important levels of respiratory morbidity persisting into adulthood. Young adult BPD survivors reported more wheeze, breathlessness and wakening with cough than non-BPD or term controls and significantly more had fixed airflow obstruction in the presence of normal or low FeNO levels and decreased diffusion capacity.
BPD survivors had radiological evidence of more severe structural lung impairment than non-BPD controls. We also observed that both preterm groups had impaired exercise capacity compared to term controls with a trend for greater exercise limitation and more leg discomfort during exercise in BPD survivors.
Our findings reaffirm the evidence suggesting adverse long term consequences of preterm birth and BPD on adult respiratory health (4, 11, (29) (30) (31) . We extend our previous observations and suggest lung function abnormalities are not confined solely to spirometric end points, but include air trapping and impaired gas transfer (12) . In the majority (75%) of BPD survivors, airflow obstruction was fixed or only partially reversible and was associated with normal or low FeNO values suggesting a non-asthmatic or at least a non-eosinophilic cause for airflow limitation.
This observation adds support to the concern that perinatal lung injury may predispose to early COPD (6) .
In a recent study by Landry and colleagues (32), adults born prematurely with BPD were more likely to have mild airflow obstruction and bronchial hyperresponsiveness than those born prematurely who did not experience BPD. We did not undertake methacholine challenge testing butthe presence of fixed airflow obstruction in a number of our subjects suggests that distinct phenotypic variants of airflow limitation exist in adult survivors of preterm birth.
Significantly lower FVC (% predicted and z scores) were observed in BPD subjects compared to term born although restrictive defects were not seen as no subjects had FVC and/or TLC measurements below the lower limit of normal. Although mean birth weights were lower in BPD subjects compared to non-BPD adjustment for birth weight did not alter our findings. As none of the non-BPD preterms were ventilated we suspect the inflammatory effects on lung development in early neonatal life due to hyperoxia and barotrauma and possible infection during the periods of mechanical ventilation have contributed to differences between the preterm groups. Lung clearance index measured by multiple breath washout is a measure of ventilation distribution which may become heterogeneous (uneven) early in diseases including asthma (33) and cystic fibrosis (34). We observed a greater proportion of adult BPD survivors with abnormal values compared to term. Although measurements were not as high as reported in bronchiectasis (29) a significant proportion (30%) of BPD subjects with normal spirometry, had abnormal lung clearance index measurements.
We investigated the association between neonatal factors and lung function in our preterm population. We adjusted for year of birth and found no evidence of a birth cohort effect. We sought to determine whether low birth weight for gestational age could explain some of our findings and report that those born SGA had greater lung function impairment than subjects born AGA. Infants with intra-uterine growth retardation are at increased risk of impaired lung function within the first few years of life (35). Here we provide evidence that impairment extends into adulthood.
Structural lung abnormalities on CT scans have been reported in children and adolescents
surviving BPD (25, 36). We found that BPD subjects have significantly more radiological abnormality compared to non-BPD controls. Subpleural opacities were the most common abnormality observed in almost all (96%) of our BPD subjects compared with less than half (46%) of non-BPD subjects. They are thought to be related to fibrotic change within the lung arising from neonatal insults such as hyperoxia and mechanical ventilation. We did not see significant bullous lung disease contrasting the findings of Wong et al, (8) . We observed significant inverse relationships between spirometry measurements and HRCT score severity and highlight important 'structure-function' consequences of preterm birth on adult lung health. We observed significantly impaired exercise capacity in preterm subjects (BPD and non BPD) compared to term controls. Following adjustments for sub-maximal exercise tests (Table E9 ) and general activity levels, these significant differences remained. BPD subjects had numerically greater reductions in peak VO2 and distance travelled on the treadmill than the preterm non-BPD controls which could possibility be due to patient effort as they achieved lower peak heart rates lower RERs. At least some of the reduction in exercise capacity in both our preterm groups may have been due to deconditioning as the VO2 at AT/peak VO2 was lower in these groups than in term controls. The slightly low oxyhemoglobin saturation and elevated ventilatory equivalents in BPD subjects suggest mild impairment of gas exchange during exercise, but these abnormalities did not limit exercise as indicated by the normal ventilatory reserve. Our finding of impaired exercise capacity in adults born preterm is in line Vrijlandt et al (9) but contrasts Narang and colleagues (11) , who observed no differences between preterm and term subjects. Their preterm group had relatively well preserved lung function and included few (n=7) BPD subjects. A recent study by Lovering and colleagues (10) identified reduced exercise capacity in adult preterm survivors which was independent of BPD or exercise induced expiratory flow limitation. We did not undertake measurements of expiratory flow or dynamic hyperinflation during exercise. However reduced lung function and low lung diffusion capacity alone do not appear to explain the reduced exercise capacity observed in adult survivors of preterm birth (37). Other unidentified aspects of BPD which might influence exercise performance include deconditioning or perception of fatigue. Landry and colleagues reported that BPD subjects tended to be more sedentary than non-BPD and term subjects (32). In line with Lovering and colleagues (10) a greater proportion of our preterm subjects reported leg discomfort during exercise which may simply reflect deconditioning but does raise the possibility of impaired peripheral muscle function as an additional longer term consequence of preterm birth.
Strengths and Limitations
A key strength was the ability to trace and study in adulthood, a group of carefully characterised preterm infants (BPD subjects and non-BPD controls) all cared for in the same hospital. Further, our study size was larger than many identified in our systematic literature review (7) .
A potential limitation of our study was the relatively low recruitment rates of preterm adults from the infants identified in the original labour records. This may have introduced bias such as exclusion of the most severely affected although the similarity of birth demographics 20 between the PALS cohort and those not responding to the study invitation suggests our findings are broadly representative of the general preterm population.
Although less applicable to infants with 'new' BPD arising from extreme prematurity, our findings are relevant to the large number of BPD survivors currently in their third and fourth decade of life many of whom may have unrecognised or incorrectly diagnosed respiratory disease. There is a need for increased awareness as recent evidence suggests that few physicians enquire about neonatal events when assessing their adult patients with pulmonary complaints (38).
None of the non-BPD subjects were ventilated during the neonatal period which does raise a potential bias when directly comparing BPD and non-BPD subjects. Further, non-BPD preterms had higher mean GA and birth weight than BPD preterms and although we undertook linear regression to simultaneously correct for these variables were we not able to adjust for all potential factors.
Finally, as this is a cross-sectional study we have no information on earlier or later lung function trajectories for this cohort. Following preterm cohorts from early life through adulthood into later life is crucial to a complete understanding the consequences of lung injury in the neonatal period. Not applicable Data are presented as mean (SD) or median (IQR). Between group comparisons made using ANOVA with Tukey-Kramer (all pairs simultaneous 95% CI) or Kruskal-Wallis ANOVA of ranks followed by Dunn's (all pairs) test. * : p<0.05, **:p<0.01,***:p<0.001 SGA: small for gestational age; AGA: appropriate for gestational age; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEF25-75%: forced expiratory flow at 25-75% of FVC, % pred.: percent predicted measurements. a n= 3 missing data, b n= 2 missing data, c n= 5 missing data, d n= 1 missing data. Bronchial wall thickening 1 (4%) 2 (9%) 0.5 (0.0, 5.7)
Conclusions
Emphysema 0 (0%) 1 (4%) n/a: not applicable, * : p<0.05, ***: p<0.001 Table 5 : 2) * 0.6 (-0.9 to 2.1) VE/VCO2 @ AT 28.1 (1.9) 27.0 (2.9) 25.9 (2.3) 1.1 (-0.6 to 2.9) 2.2 (0.5 to 3.9) ** 1.1 (-0.6 to 2.8) SpO2 at peak 96 (95 to 98) 96 (95 to 97) 97 (96 to 98) 0 (-1 to 1)) -1 (-2 to 0) -1 (-2 to 0) * Modified Borg score (0-10) 8 (7 to 10) 9 (8 to 10) 8 (8 to 9) -1 (-1 to 1) 0 (-1 to 1) 1 (0 to 1) Data are presented as mean (SD) or median (IQR). Between group comparisons made using ANOVA with Tukey-Kramer (all pairs simultaneous 95% CI) or Kruskal-Wallis ANOVA of ranks followed by Dunn's (all pairs) test. *: p<0.05, **: p<0.01, ***: p<0.001. FEV1: forced expiratory volume in 1 s , L/min: litres per minute, Vt L: tidal volume litres, Peak VO2: oxygen uptake at peak exercise, AT: anaerobic threshold, VE/VO2 @ AT: Ventilatory equivalent for oxygen, VE/VCO2 @ AT: Ventilatory equivalent for carbon dioxide. 
